Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians

AIDS

Volumn 17, Issue 6, 2003, Pages 815-819

  Mekonnen, Yared ^a,d   Dukers, Nicole H T M ^a,b   Sanders, Eduard ^a   Dorigo, Wendelien ^a   Wolday, Dawit ^a   Schaap, Ab ^a   Geskus, Ronald B ^b   Coutinho, Roel A ^a,b   Fontanet, Arnaud ^a,b,c  

^a Ethio Netherlands AIDS Research Project ENARP   (Ethiopia)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c INSTITUT PASTEUR   (France)

^d ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

Author keywords

Africa; Antiretroviral therapy; Cohort study; HIV; Prognosis markers

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BODY MASS; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG CONTRAINDICATION; ETHIOPIA; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; ETHIOPIA; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT; MALE; PATIENT SELECTION; PRACTICE GUIDELINES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; VIRAL LOAD;

EID: 0038640533     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304110-00006     Document Type: Article

References (11)

1. Department of Health and Human Services (DHHS) and the Henry J. Keiser Family Foundation. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Washington, DC: U.S. Government Printing Office. 13 August 2001.
2. World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Guidelines for a Public Health Approach. Executive Summary WHO/HIV/2002.01. Geneva: WHO; 2002.
3. Farmer P, Léandre F, Mukherjee JS, Claude MS, Nevil P, Smith-Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001, 358:404-409.
4. Sahlu T, Kassa E, Agonafer T, Tsegaye A, Rinke de Wit TF, Gebremariam H, et al. Sexual behaviours, perception of risk of HIV infection, and factors associated with attending HIV post-test counselling in Ethiopia. AIDS 1999, 13:1263-1272.
5. Kassa E, Rinke de Wit TF, Hailu E, Hailu E, Girma M, Messele T, et al. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 1999, 13:381-389.
6. World Health Organization. Acquired immune deficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemol Rec 1990, 65:221-228.
7. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med, 1997, 126:946-954.
8. UN/FAO. Body Mass Index - a Measurement of Chronic Deficiency in Adults. Food and Nutrition Paper 56. Rome: FAO; 1994.
9. Centers for Disease Control. Recommendations to prevent and control iron deficiency in the United States. MMWR 1998, 47(RR-3):1-36.
10. Hillman RS, Ault KA. Lymphopenia and immune deficiency. In: Hematology in Clinical Practice. A Guide to Diagnosis and Management. Edited by Hillman RS, Ault KA. London: Mc GrawHill; 1995:314-323.
11. Tsegaye A, Messele T, Tilahun T, Hailu E, Sahlu T, Doorly R, et al. Immuno-haematological reference ranges for adult Ethiopians. Clin Diag Lab Immunol 1999, 6:410-414.